INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 174 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $467,000 | +10.7% | 3,275 | -0.2% | 0.02% | +21.4% |
| Q1 2016 | $422,000 | -83.4% | 3,283 | -68.8% | 0.01% | -84.1% |
| Q2 2015 | $2,541,000 | -74.9% | 10,526 | -70.7% | 0.09% | -74.9% |
| Q1 2015 | $10,123,000 | +102.5% | 35,895 | +70.0% | 0.35% | +83.8% |
| Q3 2014 | $4,999,000 | -49.6% | 21,119 | -49.7% | 0.19% | -40.7% |
| Q2 2014 | $9,926,000 | -36.1% | 41,949 | -11.0% | 0.32% | -34.2% |
| Q1 2014 | $15,545,000 | +552.3% | 47,136 | +35.1% | 0.49% | +468.6% |
| Q4 2013 | $2,383,000 | – | 34,896 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |